AzTrials
AzTrials

Pressure UlcerNCT06438042

Prevention of Pressure Ulcers in Patients at High Risk of Developping Pressure Ulcers Using the Low-pressure Motorized Air Support Mattress With XTECH®25 Control Unit

An observational study of Pressure Ulcer, run by SYSTAM at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to determine the clinical value of using a a low air pressure motorised therapeutic mattress in the prevention of pressure injury (PI) in patients at medium to high risk. This study is noncomparative, observational study. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pressure Ulcer
What is being tested?
Use of a powered low air pressure motorised therapeutic mattress that combines the motorised and static technologies
Type of treatment
Medical device
How many people
80 participants
Where
1 siteFrance
Study dates
11 Jun 2024to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients in nursing homes or long-stay geriatrics department

Who may be able to join

  • Patient over 18 years old
  • Patient with high risk of developing pressure ulcers (clinical judgment and a score <= 12 on the Braden scale (6 (maximum risk) to 23 (no risk))
  • Patient without pressure injury on the day of inclusion
  • Patient up lying more than 20 hours a day on XTECH®25 mattress
  • Patient with a weight < 200 kg
  • Patient (or a trusted third party) having been informed of the study and agreeing to participate

Who cannot join

  • Patient at end of life (estimated life expectancy less than 6 months)
  • Patient discharge from the establishment expected within two months
  • Participants will be excluded from the study if they meet the following combination of criteria indicative of malnutrition according to the 2021 Haute Autorité de la Santé guidelines (Participants must meet at least one phenotypic criterion and one etiological criterion to be considered malnourished and therefore ineligible for inclusion in the study) :
  • One or more of the following phenotypic criteria:
  • Significant unintentional weight loss: A weight loss of ≥ 5% within 1 month or ≥ 10% within 6 months
  • Low Body Mass Index (BMI): BMI < 18.5 kg/m² for individuals under 70 years old, BMI < 21 kg/m² for individuals aged 70 years and older
Show all 14Show fewer
  • Reduced Muscle Mass
  • Evident reduction in muscle mass AND
  • One of the following etiological criteria:
  • Inadequate nutritional intake:
  • Nutritional intake less than 50% of the energy requirements for more than one week
  • Reduced food intake for more than two weeks
  • Presence of Disease or Stress Metabolism
  • Acute or chronic illness, or any condition causing metabolic stress that increases energy requirements .

Trial locations and contacts

1 site in 1 country.

Renaud URBINELLI contact

0756882093

contact@clin-experts.fr

France1 site, 1 recruiting
  • Multiples locations

    Multiple Locations

    Recruiting

Other trials in France

About this study

The aim of the study is to determine the clinical value of using a a low air pressure motorised therapeutic mattress in the prevention of pressure injury (PI) in patients at medium to high risk.

This study is noncomparative, observational study.

Read more

Patients older than 18 years of age, with a high risk of PI, without PI, lying more than 20 hours a day on a XTECH®25 mattress will be included. The study will be conducted in nursing homes, and in long-stay geriatrics department.

Patients are followed up for 35 days. The use of the XTECH®25 mattress is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who developed between day 0 and day 35 at least one PI of at least stage 2 on the sacrum, spine, or heel. Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Conditions
Pressure Ulcer
Being tested
Use of a powered low air pressure motorised therapeutic mattress that combines the motorised and static technologies
Keywords
Prevention, Pressure ulcer, Low air pressure motorised mattress
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Use of a powered low air pressure motorised therapeutic mattress that combines the motorised and static technologiesDevice

    Patients with a high risk of pressure injury, without pressure injury, lying more than 20 hours a day, will ly a on a XTECH®25 mattress

Study groups in NCT06438042
Study groupRoleWhat they receive
Patients in nursing homes or long-stay geriatrics departmentNot described
Receives: Device: Use of a powered low air pressure motorised therapeutic mattress that combines the motorised and static technologies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of patients who developed at least one stage 2 pressure injury

    Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)

    Measured: 35 days after installation on the mattress (at day 35)

Secondary outcomes (5)
  1. Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between

    Measured: 35 days after installation on the mattress (at day 35)

  2. Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)

    On a scale from 0 (not satisfied at all) to 4 (very satisfied)

    Measured: 35 days after installation on the mattress (at day 35)

  3. Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)

    On a scale from 0 (not satisfied at all) to 4 (very satisfied)

    Measured: 35 days after installation on the mattress (at day 35)

  4. Assessment of the degree of maceration

    On a scale from 1 (constantly moist) to 4 rarely moist

    Measured: On a scale from 1 (constantly moist) to 4 rarely moist

  5. Assessment of mattress safety

    By collecting any adverse event or mattress malfunction during the follow up

    Measured: At day 35

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2024
  2. Study start11 Jun 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06438042
Sponsor's protocol ID
2023-A01556-39
Status last verified
Jun 2024
First submitted
26 May 2024
Last updated
18 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pressure Ulcer, run by SYSTAM at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Renaud URBINELLI (0756882093, contact@clin-experts.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of patients who developed at least one stage 2 pressure injury (time frame: 35 days after installation on the mattress (at day 35)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in